April 1, 2026 · Form 4 insider transaction
Doyle Mittie bought 679 shares of Avalo Therapeutics, Inc. at $8.04 per share, a transaction worth $5.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025.